Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
L0STuP24A1MR4aEE
